[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$2335bHims & Hers Health (HIMS) Q3 earnings beat expectations with revenue at $599M, but EPS missed estimates. The company has narrowed its FY25 revenue guidance to $2.335B-$2.355B and is in discussions to offer Wegovy injections.
$2335b is a cryptocurrency.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXX +30,238%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX +2,058%
1 Year: XXXXXXX +1,031%
1-Year High: XXXXXXX on 2025-10-02
1-Year Low: X on 2025-02-06
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Week: X -XX%
1 Month: XX -XX%
6 Months: XX +120%
1 Year: XX +778%
1-Year High: XX on 2025-10-02
1-Year Low: X on 2024-11-21
| Social Network | X |
|---|---|
| Mentions | XX |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $2335b in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: X +350%
1 Month: XX -XX%
6 Months: XX +130%
1 Year: XX +813%
1-Year High: XX on 2025-10-02
1-Year Low: X on 2024-11-21
The most influential creators that mention $2335b in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @grok | X | XXXXXXXXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Month: XXX% no change
1-Year High: XXX% on 2025-10-01
1-Year Low: XX% on 2025-10-08
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | X% | XX | X% | XX | X% |
| Total | XX | X% | XX | X% | XX | X% |
Top assets mentioned In the posts about $2335b in the last XX hours
Hims & Hers Health, Inc. (HIMS) Hims & Hers Health, Inc. (HIMS)
Top topics mentioned In the posts about $2335b in the last XX hours
$2355b, hims hers, stocks consumer defensive, $hims, $307m, $598976m, $580241m, $2300b, $2400b, $2341b, $605m, $625m, $55m, $317m, $599m, novo, $16m, investment, $5793m, $60m, $600m, $5795m, has been, $5990m, $5799m, $6296m, $65msees, $234b, $312m, cash flow, subscribers, $784m, $158m
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Hims & Hers Q3 2025 highlights: Revenue hit $599M (+49% YoY) net income $15.8M Adj. EBITDA $78.4M (+53%). Subscribers grew XX% to 2.47M. Gross margin 74%. Key moves: Wegovy talks with Novo new longevity & lab testing launches Zava integration for Europe. FY25 guidance: Revenue $2.335B-$2.355B Adj. EBITDA $307M-$317M. Strong cash flow supports growth"
X Link @grok 2025-11-04T16:33Z 6.6M followers, XX engagements
"$HIMS Hims & Hers reports Q3 EPS 6c consensus 10c Q3 revenue $599.0M consensus $579.9M. Sees Q4 revenue $605M-$625M consensus $629.6M. Sees Q4 adjusted EBITDA $55M-$65M.Sees FY25 revenue $2.335B-$2.355B consensus $2.34B Sees FY25 adjusted EBITDA $307M-$312M"
X Link @John_Porter10 2025-11-03T22:46Z 4567 followers, XXX engagements
"The acquisition enabling comprehensive lab testing was announced Feb XX 2025. It's trueHims & Hers acquired Trybe Labs for at-home blood testing rollout expected within the year (by early 2026 possibly 2025 per site). Website shows "Coming soon." Latest guidance from Q3 earnings today: FY2025 revenue $2.335B-$2.355B Adj. EBITDA $307M-$317M"
X Link @grok 2025-11-03T21:35Z 6.6M followers, XX engagements
"$HIMS Earnings are out Revenue: $599M 🟢 EPS: $0.06🔴 Guidance for Q4: Revenue:$605M-$625M Adj. EBITDA- $55M-$60M Full year: Revenue of $2.335B- $2.355B Adj. EBITDA of $307M-$317M"
X Link @InvestChameleon 2025-11-03T21:32Z XXX followers, XXX engagements